These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34761681)

  • 1. Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age?
    Dhakal P; Wichman CS; Pozehl B; Weaver M; Fisher AL; Vose J; Bociek RG; Bhatt VR
    Future Oncol; 2022 Jan; 18(3):311-321. PubMed ID: 34761681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of physicians' perspectives versus patients' preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma.
    Mühlbacher AC; Nübling M
    Eur J Health Econ; 2011 Jun; 12(3):193-203. PubMed ID: 20107856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with a preference for disclosure of life expectancy information from physicians: a cross-sectional survey of cancer patients undergoing radiation therapy.
    Uchida M; Sugie C; Yoshimura M; Suzuki E; Shibamoto Y; Hiraoka M; Akechi T
    Support Care Cancer; 2019 Dec; 27(12):4487-4495. PubMed ID: 30911915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV).
    Rohr I; Alavi S; Richter R; Keller M; Chekerov R; Oskay-Özcelik G; Heinrich M; Taskiran C; Joly F; Berger R; du Bois A; Gornjec A; Vergote I; Achimas-Cadariu P; Lorusso D; Maenpaa J; Sehouli J
    Int J Gynecol Cancer; 2020 Apr; 30(4):509-514. PubMed ID: 32139438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older Adults' Views and Communication Preferences About Cancer Screening Cessation.
    Schoenborn NL; Lee K; Pollack CE; Armacost K; Dy SM; Bridges JFP; Xue QL; Wolff AC; Boyd C
    JAMA Intern Med; 2017 Aug; 177(8):1121-1128. PubMed ID: 28604917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social and clinical determinants of preferences and their achievement at the end of life: prospective cohort study of older adults receiving palliative care in three countries.
    Higginson IJ; Daveson BA; Morrison RS; Yi D; Meier D; Smith M; Ryan K; McQuillan R; Johnston BM; Normand C;
    BMC Geriatr; 2017 Nov; 17(1):271. PubMed ID: 29169346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient preferences for oral versus intravenous palliative chemotherapy.
    Liu G; Franssen E; Fitch MI; Warner E
    J Clin Oncol; 1997 Jan; 15(1):110-5. PubMed ID: 8996131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding health outcome preferences of older adults diagnosed with multiple myeloma.
    Maheshwari S; Arias M; Ubersax C; Tucker A; Bal S; Ravi G; Godby K; Costa LJ; Williams GR; Shrestha S; Bhatia S; Giri S
    J Geriatr Oncol; 2024 Jun; 15(5):101781. PubMed ID: 38714092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Comparison of Younger and Older Patients' Preferences for Adjuvant Chemotherapy and Hormonal Therapy in Early Breast Cancer.
    Hamelinck VC; Bastiaannet E; Pieterse AH; de Glas NA; Portielje JE; Merkus JW; den Hoed ID; van de Velde CJ; Liefers GJ; Stiggelbout AM
    Clin Breast Cancer; 2016 Oct; 16(5):379-388. PubMed ID: 27212474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Do Older Adults Consider Age, Life Expectancy, Quality of Life, and Physician Recommendations When Making Cancer Screening Decisions? Results from a National Survey Using a Discrete Choice Experiment.
    Janssen EM; Pollack CE; Boyd C; Bridges JFP; Xue QL; Wolff AC; Schoenborn NL
    Med Decis Making; 2019 Aug; 39(6):621-631. PubMed ID: 31226903
    [No Abstract]   [Full Text] [Related]  

  • 11. Eliciting preferences to inform patient-centred policies: the case of psoriasis.
    Torbica A; Fattore G; Ayala F
    Pharmacoeconomics; 2014 Feb; 32(2):209-23. PubMed ID: 24446282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' and oncologists' preferences for second-line maintenance PARP inhibitor therapy in epithelial ovarian cancer.
    Stone RL; Cambron-Mellott MJ; Beusterien K; Maculaitis MC; Ritz S; Mulvihill E; Monberg M; Szamreta EA; Amin S; McLaurin K
    Future Oncol; 2022 Feb; 18(4):491-503. PubMed ID: 34875854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older Adults' Preferences for Discussing Long-Term Life Expectancy: Results From a National Survey.
    Schoenborn NL; Janssen EM; Boyd C; Bridges JFP; Wolff AC; Xue QL; Pollack CE
    Ann Fam Med; 2018 Nov; 16(6):530-537. PubMed ID: 30420368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Stability of Treatment Preferences Among Patients With Advanced Cancer.
    Jabbarian LJ; Maciejewski RC; Maciejewski PK; Rietjens JAC; Korfage IJ; van der Heide A; van Delden JJM; Prigerson HG
    J Pain Symptom Manage; 2019 Jun; 57(6):1071-1079.e1. PubMed ID: 30794935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens.
    Havrilesky LJ; Scott AL; Davidson BA; Secord AA; Yang JC; Johnson FR; Gonzalez JM; Reed SD
    Gynecol Oncol; 2021 Aug; 162(2):440-446. PubMed ID: 34053748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment preferences among Japanese patients and physicians for epidermal growth factor receptor-mutant non-small cell lung cancer.
    Hata A; Fifer S; Hasegawa K; Ando E; Kasahara-Kiritani M; Takahashi M; Ordman R; Toh L; Inoue A
    Cancer Med; 2024 Jan; 13(1):e6777. PubMed ID: 38196301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful Benefits.
    Richardson DR; Crossnohere NL; Seo J; Estey E; O'Donoghue B; Smith BD; Bridges JFP
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):942-948. PubMed ID: 32132149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why do some patients prefer to leave decisions up to the doctor: lack of self-efficacy or a matter of trust?
    Chawla N; Arora NK
    J Cancer Surviv; 2013 Dec; 7(4):592-601. PubMed ID: 23892559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferred and Perceived Participation of Younger and Older Patients in Decision Making About Treatment for Early Breast Cancer: A Prospective Study.
    Hamelinck VC; Bastiaannet E; Pieterse AH; van de Velde CJH; Liefers GJ; Stiggelbout AM
    Clin Breast Cancer; 2018 Apr; 18(2):e245-e253. PubMed ID: 29275105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients.
    Teuffel O; Cheng S; Ethier MC; Diorio C; Martino J; Mayo C; Wing R; Sung L; Alibhai SM
    Support Care Cancer; 2012 Nov; 20(11):2755-64. PubMed ID: 22350594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.